Nextleaf Solutions Adds Former Health Canada
Inspector Dr. Sherry Boodram to Board of Directors
VANCOUVER, Canada -- October 16, 2019 -- InvestorsHub NewsWire --
Nextleaf Solutions Ltd. ("Nextleaf",
"OILS", or the "Company")
(CSE: OILS) (OTCQB: OILFF) (FSE:
L0MA), an extraction technology company that owns a
portfolio of eight (8) issued and 35 pending patents pertaining to
industrial-scale extraction, purification and formulation of
cannabinoids, announced today that it has added Dr. Sherry
Boodram, former Senior Regulatory Compliance Officer with Health
Canada, to its Board of Directors, effective immediately.
Dr. Sherry Boodram (CNW Group/Nextleaf
Solutions Ltd.)
Currently, Dr. Boodram is the co-founder and CEO of CannDelta Inc.
("CannDelta") - a regulatory and scientific
cannabis consulting company based out of Toronto,
Canada - where she provides regulatory expertise and develops
strategies to ensure regulatory compliance
within Canada's existing legal cannabis framework.
"The serious regulatory infractions by several large Canadian
licensed cannabis producers, along with an expanded scope of
cannabis products through legalization 2.0, reinforces the critical
role that compliance oversight plays in building a cannabis company
all stakeholders can be proud of," stated Paul Pedersen,
co-founder and CEO of Nextleaf Solutions. "Sherry is amongst the
most credible and qualified cannabis regulatory experts
in Canada, and we believe her background, insights, and
industry experience will add tremendous value to our Board."
Prior to founding CannDelta, Dr. Sherry
Boodram spent several years in the Canadian federal
government, most notably with Health Canada's Medical Cannabis
Program as a Senior Regulatory Compliance and Enforcement Officer.
She was responsible for licensing application reviews and on-site
facility inspections under the legislative regimes of
the Marihuana for Medical Purposes
Regulations (MMPR) and Access to Cannabis for
Medical Purposes Regulations (ACMPR). Dr. Boodram also
provided field level input during the drafting of the
current Cannabis Regulations.
"Being a company with values I can stand
behind, I'm very excited to serve alongside Nextleaf's existing
Board members and with their talented executive team," stated
Dr. Sherry Boodram. "Moreover, I look forward to maximizing
the unique knowledge and experience I gained while at Health
Canada's Medical Cannabis Program, and in the cannabis industry as
a whole, to provide expertise in support of Nextleaf's ongoing
commitment to regulatory compliance, good governance, and long-term
growth as a leader in cannabis extraction technology."
Dr. Boodram holds a Ph.D. in Chemistry from York
University, a B.Sc. (Hon) from the University of Toronto, and
a Graduate Certificate with Honours in Pharmaceutical Regulatory
Affairs and Quality Operations from Seneca College. Dr.
Boodram is also a member of the Canadian Association of
Professionals in Regulatory Affairs (CAPRA).
Option Grant
The Company has awarded a director of the Company
options to purchase up to 150,000 common shares of the Company
pursuant to the Company's Stock Option Plan, exercisable at a price
of $0.50 per share.
About Nextleaf
Solutions
Nextleaf Solutions Ltd.
("OILS") is developing disruptive intellectual
property for industrial-scale extraction, purification and
formulation of cannabinoids. OILS owns a portfolio of eight (8)
issued and 35 pending patents pertaining to the production of
high-purity, cannabinoid rich distillate, the key ingredient used
in the manufacturing of standardized THC and CBD infused products.
Once cannabis concentrates and edibles become legal
across Canada, OILS plans to commercialize its intellectual
property portfolio through IP licensing, B2B processing services,
and the supply of THC and CBD oils and concentrates to qualified
Canadian and international partners.
Nextleaf Solutions trades as OILS on
the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB
Market in the United States (OTCQB: OILFF) and
L0MA on the Frankfurt Stock Exchange (FSE:
L0MA).
For more
information visit www.nextleafsolutions.com or follow OILS across
social media platforms: Twitter, LinkedIn, Facebook, and Instagram.
Contact:
Adel Fares, Investor Relations
604-283-2301 (ext. 201)
investors@nextleafsolutions.com
CAUTIONARY STATEMENT:
Certain statements contained in this press release constitute
"forward-looking statements". All statements other than statements
of historical fact contained in this press release, including,
without limitation, the strategy, plans, objectives, goals and
targets of each of the Company, and any statements preceded by,
followed by or that include the words "believe", "expect", "aim",
"intend", "plan", "continue", "will", "may", "would", "anticipate",
"estimate", "forecast", "predict", "project", "seek", "should" or
similar expressions or the negative thereof, are forward-looking
statements. These statements are not historical facts but instead
represent only the Company's expectations, estimates and
projections regarding future events. These statements are not
guarantees of future performance and involve assumptions, risks and
uncertainties that are difficult to predict. Therefore, actual
results may differ materially from what is expressed, implied or
forecasted in such forward-looking statements. Additional factors
that could cause actual results, performance or achievements to
differ materially include, but are not limited to the risk factors
discussed in the Company's MD&A for the most recent fiscal
period. Management provides forward-looking statements because it
believes they provide useful information to investors when
considering their investment objectives and cautions investors not
to place undue reliance on forward-looking information.
Consequently, all of the forward-looking statements made in this
press release are qualified by these cautionary statements and
other cautionary statements or factors contained herein, and there
can be no assurance that the actual results or developments will be
realized or, even if substantially realized, that they will have
the expected consequences to, or effects on, the Company. These
forward-looking statements are made as of the date of this press
release and the Company assumes no obligation to update or revise
them to reflect subsequent information, events or circumstances or
otherwise, except as required by law. The CSE has not reviewed,
approved or disapproved the contents of this press release.
SOURCE: Nextleaf Solutions Ltd.
Nextleaf Solutions (CSE:OILS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Nextleaf Solutions (CSE:OILS)
Historical Stock Chart
From Nov 2023 to Nov 2024
